Bifogade filer
Kurs
-1,73%
Likviditet
0,52 MNOK
Kalender
Tid* | ||
2025-08-28 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-06-05 | N/A | Årsstämma |
2025-04-10 | 00:00 | Bokslutskommuniké 2024 |
2024-08-29 | - | Kvartalsrapport 2024-Q2 |
2024-06-19 | - | Årsstämma |
2024-06-06 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2024-04-25 | - | Bokslutskommuniké 2023 |
2023-10-04 | - | Split CRNA 30:1 |
2023-08-24 | - | Kvartalsrapport 2023-Q2 |
2023-05-22 | - | Årsstämma |
2023-04-21 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2023-03-09 | - | Extra Bolagsstämma 2023 |
2023-02-16 | - | Bokslutskommuniké 2022 |
2022-11-03 | - | Kvartalsrapport 2022-Q3 |
2022-08-18 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-04-20 | - | Årsstämma |
2022-04-07 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2022-02-17 | - | Bokslutskommuniké 2021 |
2021-11-25 | - | Extra Bolagsstämma 2021 |
2021-11-04 | - | Kvartalsrapport 2021-Q3 |
2021-08-18 | - | Kvartalsrapport 2021-Q2 |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-03-18 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2021-03-17 | - | Årsstämma |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-05 | - | Kvartalsrapport 2020-Q3 |
2020-08-20 | - | Kvartalsrapport 2020-Q2 |
2020-05-07 | - | Kvartalsrapport 2020-Q1 |
2020-04-30 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2020-04-29 | - | Årsstämma |
2020-03-11 | - | Bokslutskommuniké 2019 |
2019-11-07 | - | Kvartalsrapport 2019-Q3 |
2019-08-22 | - | Kvartalsrapport 2019-Q2 |
2019-05-09 | - | Kvartalsrapport 2019-Q1 |
2019-04-10 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2019-04-09 | - | Årsstämma |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-11-01 | - | Kvartalsrapport 2018-Q3 |
2018-08-23 | - | Kvartalsrapport 2018-Q2 |
2018-05-03 | - | Kvartalsrapport 2018-Q1 |
2018-04-12 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2018-04-11 | - | Årsstämma |
2018-02-15 | - | Bokslutskommuniké 2017 |
2017-11-16 | - | Kvartalsrapport 2017-Q3 |
2017-08-24 | - | Kvartalsrapport 2017-Q2 |
2017-04-25 | - | Kvartalsrapport 2017-Q1 |
2017-04-05 | - | Årsstämma |
2017-02-16 | - | Bokslutskommuniké 2016 |
2016-11-17 | - | Kvartalsrapport 2016-Q3 |
2016-08-25 | - | Kvartalsrapport 2016-Q2 |
2016-05-12 | - | Kvartalsrapport 2016-Q1 |
2016-04-14 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2016-04-13 | - | Årsstämma |
2015-06-23 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
2015-06-22 | - | Årsstämma |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN.
Oslo, 19 June 2024: Circio Holding ASA (the "Company") held its annual general meeting today, 19 June 2024, as a physical meeting at the Company's offices at St. Olavs Plass 5, 0165 Oslo.
All resolutions were made in accordance with the proposals from the board of directors and the nomination committee, including, but not limited to, approval of the 2023 annual accounts, election of members to the board of directors and the authorisations to the board of directors, and several matters relating to the rights issue to be carried out in the Company to raise gross proceeds of up to approximately NOK 52 million (the "Rights Issue") and the conversion of convertible bonds of NOK 15 million by Atlas Special Opportunities, LLC ("Atlas") (the "Conversion").
The minutes from the annual general meeting are attached hereto and will also be made available on the Company's website http://www.circio.com under the heading "Investors".
The full terms and conditions for the Rights Issue is included in a prospectus, comprising of a registration document supplement, a securities note and a summary, all dated 18 June 2024, and a registration document approved on 28 September 2023 and a registration document supplement approved on 8 March 2024 (jointly, the "Prospectus"). Subject to applicable local securities laws, the Prospectus and the subscription form for the Rights Issue, attached to the Securities Note, is made available at the Company's website: https://www.circio.com/en/rights-issue-2024/. The subscription period for the Rights Issue is expected to take place from 09:00 hours (CEST) on 24 June 2024 to 8 July 2024 at 16:30 hours (CEST).
Erik Digman Wiklund, CEO
Phone: +47 413 33 536
Email: erik.wiklund@circio.com
Lubor Gaal, CFO
Phone: +34 683343811
Email: lubor.gaal@circio.com